CALGARY, Alberta, Aug. 04, 2023 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused on
Related Keywords
James Fairbairn , Nick Rigopulos , Jim Fairbairn , Amar Keshri , Allen Davidoff , David Melamed , Therapeutics Inc , Chief Financial Officer , Interim Chief Financial Officer , Chartered Professional Accountant ,
comparemela.com © 2020. All Rights Reserved.